Literature DB >> 28506853

Expression of semaphorin 3E is suppressed in severe asthma.

Hesam Movassagh1, Lianyu Shan1, Jamila Chakir2, John F McConville3, Andrew J Halayko4, Latifa Koussih1, Abdelilah S Gounni5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28506853     DOI： 10.1016/j.jaci.2017.04.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

2.  Semaphorin3E/plexinD1 Axis in Asthma: What We Know So Far!

Authors:  Latifa Koussih; Abdelilah S Gounni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Downregulation of semaphorin 3E promotes hallmarks of experimental chronic allergic asthma.

Authors:  Hesam Movassagh; Lianyu Shan; Jonathan S Duke-Cohan; Jamila Chakir; Andrew J Halayko; Latifa Koussih; Abdelilah S Gounni
Journal:  Oncotarget       Date:  2017-10-27

Review 4.  Immunologic and Non-Immunologic Mechanisms Leading to Airway Remodeling in Asthma.

Authors:  Lei Fang; Qinzhu Sun; Michael Roth
Journal:  Int J Mol Sci       Date:  2020-01-23       Impact factor: 5.923

Review 5.  View Point: Semaphorin-3E: An Emerging Modulator of Natural Killer Cell Functions?

Authors:  Abdulaziz Alamri; Abdelilah Soussi Gounni; Sam K P Kung
Journal:  Int J Mol Sci       Date:  2017-11-05       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.